Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
Abstract Background The management of COVID-19 in organ transplant recipients is among the most imperative, yet less discussed, issues based on their immunocompromised status along with their vast post-transplant medication regimens. No conclusive study has been published to evaluate proper anti-vir...
Guardado en:
Autores principales: | Mojtaba Shafiekhani, Farbod Shahabinezhad, Tahmoores Niknam, Seyed Ahmad Tara, Elham Haem, Parviz Mardani, Zahra Zare, Sedigheh Jafarian, Khatereh Mirzad Jahromi, Sara Arabsheybani, Yalda Sadat Moeini, Jalile Alavi, Seyed Soroush Jalali, Maryam Salimi, Reza Shahriarirad, Seyed Ali Malekhosseini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eac925369cb847e99d332d05592db228 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
por: Federica Filippi, et al.
Publicado: (2019) -
Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
por: Bogna Grygiel-Górniak, et al.
Publicado: (2021) -
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
por: Stephen I. Walimbwa, et al.
Publicado: (2021) -
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
por: Dimitrios Sagris, et al.
Publicado: (2021) -
Safety and heart rate changes in Covid-19 patients treated with Remdesivir
por: Natale Daniele Brunetti, MD, PhD, et al.
Publicado: (2021)